Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryn Nelson

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Cancer Cytopathology|July 22, 2014
Fair share? Journal editors, researchers, and others grapple over whether research and clinical data should be sharedBryn Nelson
Cancer Cytopathology|October 15, 2014
Hospital rooms with a view: countries and foreign clinics are vying to become the go-to destinations for medical tourists. Is it worth it?Bryn Nelson
Cancer Cytopathology|June 15, 2013
Weighty talks about wise choices: a new campaign urges pathologists to be the voice of caution on test ordersBryn Nelson
Cancer Cytopathology|February 17, 2016
The right prescriptions for reducing diagnostic errors?: Institute of Medicine report issues wakeup call on errors, but questions remain concerning key recommendationsBryn Nelson
BMJ (Clinical Research Ed.)|April 8, 2020
Seattle's covid-19 lessons are yielding hopeBryn Nelson
Cancer Cytopathology|August 8, 2019
Troubling blind spots in understanding cancer risks among transgender patients: Bias, discrimination, and a lack of good data may be impeding cancer screening and risk assessments for the transgender population. In this article, the second of a 2-part series, we explore the remaining gaps in understanding and communicating the risksBryn Nelson
Cancer Cytopathology|February 15, 2014
Racing into the unknown: the field of noninvasive prenatal testing is in overdrive. But where is it heading?Bryn Nelson
Cancer Cytopathology|March 20, 2019
Reassessing the risk of kidney organ donation: Researchers are taking a closer look at the long-term health risks that living kidney donors may face to refine the informed consent process and improve follow-up careBryn Nelson
Nature|May 9, 2014
Synthetic biology: Cultural divideBryn Nelson
Cancer Cytopathology|June 17, 2014
Tapping the wisdom of the crowd: new initiatives are engaging the public as active participants in biomedical researchBryn Nelson
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Cancer Cytopathology|July 22, 2014
Fair share? Journal editors, researchers, and others grapple over whether research and clinical data should be sharedBryn Nelson
Cancer Cytopathology|October 15, 2014
Hospital rooms with a view: countries and foreign clinics are vying to become the go-to destinations for medical tourists. Is it worth it?Bryn Nelson
Cancer Cytopathology|June 15, 2013
Weighty talks about wise choices: a new campaign urges pathologists to be the voice of caution on test ordersBryn Nelson
Cancer Cytopathology|February 17, 2016
The right prescriptions for reducing diagnostic errors?: Institute of Medicine report issues wakeup call on errors, but questions remain concerning key recommendationsBryn Nelson
BMJ (Clinical Research Ed.)|April 8, 2020
Seattle's covid-19 lessons are yielding hopeBryn Nelson
Cancer Cytopathology|August 8, 2019
Troubling blind spots in understanding cancer risks among transgender patients: Bias, discrimination, and a lack of good data may be impeding cancer screening and risk assessments for the transgender population. In this article, the second of a 2-part series, we explore the remaining gaps in understanding and communicating the risksBryn Nelson
Cancer Cytopathology|February 15, 2014
Racing into the unknown: the field of noninvasive prenatal testing is in overdrive. But where is it heading?Bryn Nelson
Cancer Cytopathology|March 20, 2019
Reassessing the risk of kidney organ donation: Researchers are taking a closer look at the long-term health risks that living kidney donors may face to refine the informed consent process and improve follow-up careBryn Nelson
Nature|May 9, 2014
Synthetic biology: Cultural divideBryn Nelson
Cancer Cytopathology|June 17, 2014
Tapping the wisdom of the crowd: new initiatives are engaging the public as active participants in biomedical researchBryn Nelson
Pageof 19